Acceder

Publicaciones - Investigación en Epidemiología y Salud Pública

Cargando...
Pinto-Carbo M, Peiro-Perez R, Molina-Barcelo A, Vanaclocha-Espi M, Alguacil J, Castano-Vinyals G, O'Callaghan-Gordo C, Gracia-Lavedan E, Perez-Gomez B, Lope V, Aragones N, Molina AJ, Fernandez-Villa T, Gil-Majuelo L, Amiano P, Dierssen-Sotos T, Gomez-Acebo I, Guevara M, Moreno-Iribas C, Obon-Santacana M, Rodriguez-Suarez MM, Salcedo-Bellido I, Delgado-Parrilla A, Marcos-Gragera R, Chirlaque MD, Kogevinas M, Pollan M, Salas D. Social mobility and healthy behaviours from a gender perspective in the Spanish multicase-control study (MCC-Spain). PLoS One. 2021 May 12;16(5):e0251447. doi: 10.1371/journal.pone.0251447. eCollection 2021. PubMed PMID: 33979362; PubMed Central PMCID: PMC8115806.
AÑO: 2021; IF: 3.752
Aglago EK, Schalkwijk CG, Freisling H, Fedirko V, Hughes DJ, Jiao L, Dahm CC, Olsen A, Tjonneland A, Katzke V, Johnson T, Schulze MB, Aleksandrova K, Masala G, Sieri S, Simeon V, Tumino R, Macciotta A, Bueno-de-Mesquita B, Skeie G, Gram IT, Sandanger T, Jakszyn P, Sanchez MJ, Amiano P, Colorado-Yohar SM, Gurrea AB, Perez-Cornago A, Mayen AL, Weiderpass E, Gunter MJ, Heath AK, Jenab M. Plasma concentrations of advanced glycation end-products and colorectal cancer risk in the EPIC study. Carcinogenesis. 2021 May 28;42(5):705-713. doi: 10.1093/carcin/bgab026. PubMed PMID: 33780524; PubMed Central PMCID: PMC8162627.
AÑO: 2021; IF: 4.741
Alvarez-Alvarez L, Vitelli-Storelli F, Rubin-Garcia M, Aragones N, Ardanaz E, Castano-Vinyals G, Obon-Santacana M, Dierssen-Sotos T, Salas-Trejo D, Tardon A, Moleon JJJ, Alguacil J, Chirlaque MD, Perez-Gomez B, Pollan M, Kogevinas M, Martin V. Relationship between the Risk of Gastric Cancer and Adherence to the Mediterranean Diet According to Different Estimators. MCC-Spain Study. Cancers (Basel). 2021 Oct 21;13(21):5281. doi: 10.3390/cancers13215281. PubMed PMID: 34771444; PubMed Central PMCID: PMC8582518.
AÑO: 2021; IF: 6.575
Katzke VA, Le Cornet C, Mahfouz R, Brauer B, Johnson T, Canzian F, Rebours V, Boutron-Ruault MC, Severi G, Schulze MB, Olsen A, Tjonneland A, Overvad K, Crous-Bou M, Molina-Montes E, Amiano P, Huerta JM, Ardanaz E, Perez-Cornago A, Masala G, Pala V, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, Vermeulen R, Sund M, Franklin O, Christakoudi S, Dossus L, Weiderpass E, Olek S, Kaaks R. Are Circulating Immune Cells a Determinant of Pancreatic Cancer Risk? A Prospective Study Using Epigenetic Cell Count Measures. Cancer Epidemiol Biomarkers Prev. 2021 Dec;30(12):2179-2187. doi: 10.1158/1055-9965.EPI-21-0169. Epub 2021 Sep 20. PubMed PMID: 34548327.
AÑO: 2021; IF: 4.09
Stacchiotti S, Frezza AM, Blay JY, Baldini EH, Bonvalot S, Bovee JVMG, Callegaro D, Casali PG, Chiang RC, Demetri GD, Demicco EG, Desai J, Eriksson M, Gelderblom H, George S, Gounder MM, Gronchi A, Gupta A, Haas RL, Hayes-Jardon A, Hohenberger P, Jones KB, Jones RL, Kasper B, Kawai A, Kirsch DG, Kleinerman ES, Le Cesne A, Lim J, Chirlaque Lopez MD, Maestro R, Marcos-Gragera R, Martin Broto J, Matsuda T, Mir O, Patel SR, Raut CP, Razak ARA, Reed DR, Rutkowski P, Sanfilippo RG, Sbaraglia M, Schaefer IM, Strauss DC, Sundby Hall K, Tap WD, Thomas DM, van der Graaf WTA, van Houdt WJ, Visser O, von Mehren M, Wagner AJ, Wilky BA, Won YJ, Fletcher CDM, Dei Tos AP, Trama A. Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer. 2021 Aug 15;127(16):2934-2942. doi: 10.1002/cncr.33618. Epub 2021 Apr 28. PubMed PMID: 33910263; PubMed Central PMCID: PMC8319065.
AÑO: 2021; IF: 6.921
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

Investigación en Epidemiología y Salud Pública